Sign In
Buy AYTU
$2.09
-0.0100 (-0.476%)
At Close: Jun 03, 2026
Edited Transcript of AYTU earnings conference call or presentation 14-May-20 8:30pm GMT
05:50am, Thursday, 25'th Jun 2020
Q3 2020 Aytu BioScience Inc Earnings Call
Aclaris Therapeutics (NASDAQ:ACRS) versus Aytu Bioscience (NASDAQ:AYTU) Financial Analysis
02:24am, Wednesday, 24'th Jun 2020
Aclaris Therapeutics (NASDAQ:ACRS) and Aytu Bioscience (NASDAQ:AYTU) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strengt
Hot Stock Evaluation- Aytu BioScience, Inc. (NASDAQ:AYTU)’s E-P-S strolling at -1.54, - Stocks Equity
07:44pm, Monday, 22'nd Jun 2020
On Monday, shares of Aytu BioScience, Inc. (NASDAQ:AYTU) reached at $1.51 price level during last trade its distance from 20 days simple moving average was [...]
Global Female Technology Market (2019 to 2030) - Featuring Bloomlife, CORA & Flo Health Among Others - ResearchAndMarkets.com
12:00am, Friday, 19'th Jun 2020
The
Aytu BioScience: The Next Arbor Pharmaceuticals?
10:47pm, Thursday, 18'th Jun 2020
Between December 2019 and March 2020, Aytu had issued almost 100M shares which diluted existing shareholders 81%. Throughout this dilution, Aytu has grown reven
Is Aytu Bioscience (AYTU) Stock Outpacing Its Medical Peers This Year?
03:30pm, Thursday, 18'th Jun 2020
Is (AYTU) Outperforming Other Medical Stocks This Year?
bluebird Reports New Data on Betibeglogene Autotemcel for TDT
02:59pm, Monday, 15'th Jun 2020
bluebird (BLUE) reports new phase III data on betibeglogene autotemcel in TDT.
Global Imaging Agents Industry (2019 to 2027) - Market Trajectory & Analytics - ResearchAndMarkets.com
12:00am, Monday, 15'th Jun 2020
The
Why Aytu BioScience (AYTU) Stock Might be a Great Pick
12:47pm, Friday, 12'th Jun 2020
Aytu BioScience (AYTU) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Utragenyx Shares Soar Above 60% YTD on Pipeline Developments
02:21pm, Thursday, 11'th Jun 2020
Ultragenyx's (RARE) shares rise more than 60% year to date on various positive pipeline developments.
Milestone Pharmaceuticals (MIST) Looks Good: Stock Adds 6.5% in Session
12:37pm, Wednesday, 10'th Jun 2020
Milestone Pharmaceuticals (MIST) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.
Monopar Therapeutics (MNPR) Catches Eye: Stock Jumps 11.2%
02:00pm, Tuesday, 09'th Jun 2020
Monopar Therapeutics (MNPR) saw a big move last session, as its shares jumped more than 11% on the day, amid huge volumes.
IDEAYA (IDYA) Looks Good: Stock Adds 10.2% in Session
12:58pm, Tuesday, 09'th Jun 2020
IDEAYA (IDYA) saw a big move last session, as its shares jumped more than 10% on the day, amid huge volumes.
Aytu BioScience Announces Results from a National Cancer Institute Evaluation of the Company’s Licensed COVID-19 IgG/IgM Rapid Test
12:00pm, Tuesday, 09'th Jun 2020
National Cancer Institute's (NCI) analysis of COVID-19 IgG/IgM Rapid Test Cassette Reported 100% Combined Sensitivity, and 97.5% Combined Specificity for the Lateral Flow Immunoassay ENGLEWOOD, CO / A
Aytu BioScience Set to Join Russell 3000(R) Index
12:00pm, Monday, 08'th Jun 2020
ENGLEWOOD, CO / ACCESSWIRE / June 8, 2020 / Aytu BioScience, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company (the "Company") focused on commercializing novel products that address significant .
